Image Wisely, a joint initiative of ACR, RSNA, ASRT and AAPM,
provides information to the medical community to promote safety in medical imaging.
Murray D. Becker, MD, PhD, University Radiology Group, East Brunswick, NJ
M. Elizabeth Oates, MD, University of Kentucky Medical Center, Lexington, KY
In gamma camera nuclear imaging, a patient’s radiation exposure depends on:
Calculating the actual radiation exposure for an individual patient is complex and multifactorial, open to uncertainty and not routinely done in the clinical setting. Nonetheless, the simplest approach to reduce patient radiation exposure is three-fold:
Reducing the administered activity of a radiopharmaceutical will reduce patient radiation exposure, but it will also affect the examination’s imaging characteristics and may lower image quality.
In the simplest terms, reducing administered activity will lower the count rate. If the examination’s other acquisition parameters are unchanged, this may result in reduced visibility of the organ(s) of interest, increased image noise and limited detection of disease. If imaging times are increased to compensate for lower count rates, then the examination may become more susceptible to patient motion artifacts. The impact of lower administered activities may be greater in certain classes of patients, such as those with large body habitus, in whom count rates are further reduced by soft-tissue attenuation. It must be noted that universally accepted guidelines that optimize imaging by accounting for body habitus (e.g., employing weight-based administered activities or adjusting gamma camera acquisition parameters according to an individual patient’s body type) do not exist; thus, care must be taken in order to maintain sufficient diagnostic image quality when using lower administered activities. The adverse impact of reduced administered activity on image quality can be mitigated by using new camera technologies and software reconstruction algorithms and techniques.1 See also Dedicated Solid State Cardiac Systems for Myocardial Perfusion Imaging.
The most effective approach to reducing patient radiation exposure is eliminating diagnostic tests that are not likely to benefit the patient. Appropriateness criteria are evidence-based expert recommendations created to optimize imaging algorithms in order to improve patient outcomes, eliminate waste and reduce variations in clinical practice. Many clinical conditions that can be evaluated by general nuclear medicine imaging are included in the American College of Radiology Appropriateness Criteria®.
Overall gamma camera performance must be optimized by applying a rigorous Quality Assurance/Quality Control program. This is especially true when acquiring images from administered activities at the lower end of the recommended range. Nuclear Medicine accreditation programs (e.g., those of the American College of Radiology and the Intersocietal Accreditation Commission) promote proper gamma camera function and, in turn, optimal image quality.
Multiple professional societies have developed practice guidelines that address clinical and technical aspects of general nuclear medicine imaging examinations, including: ACR, Society of Nuclear Medicine and Molecular Imaging, European Association of Nuclear Medicine, American Association of Clinical Endocrinologists and American Thyroid Association.
It should be emphasized that when a physician uses diagnostic nuclear medicine imaging, the best strategy is two-fold: first, choose the imaging examination that will appropriately answer the clinical question, and second, perform that examination to the highest technical standards. Nuclear medicine imaging examinations are safe and effective; avoiding these examinations because they use small amounts of radioactivity, or choosing a particular examination solely because it uses less radiation than an alternative examination, can be detrimental to the patient (SNMMI Position Statement on Dose Optimization). Please refer to the physics section of this Image Wisely website for a more technical and detailed discussion of this topic in the article Appropriate Use of Effective Dose and Organ Dose in Nuclear Medicine.
Taken together, the fundamental Image Wisely goals in general nuclear medicine imaging are:
Seven common general nuclear medicine imaging examinations are presented below. Each table highlights key performance considerations and emphasizes the use of published practice guidelines and appropriateness criteria. The tables are not comprehensive guidelines, and they only address a limited number of clinical scenarios, but they illustrate how expert consensus opinion can be used to optimize the choice of radiopharmaceutical and imaging protocol.
I. Bone Scintigraphy
II. Parathyroid Scintigraphy
III. Thyroid Scintigraphy and Uptake
IV. Scintigraphy for Differentiated Papillary and Follicular Thyroid Cancer
V. Lung (V/Q) Scintigraphy
VI. Radionuclide Infection Imaging
VII. Hepatobiliary Scintigraphy
|Radiopharmaceuticals||99mTc diphosphonates (HDP, MDP)|
|Recommended Adult Administered Activity1,2||15-30 mCi (740-1,110 MBq) IV
Higher doses may be considered in obese patients
|Performance Considerations||Administer lowest activity in prescribed range
Balance acquisition duration versus image quality
|Maneuvers to Minimize Radiation Dose1,2||2 or more 8-oz glasses of water after administration
Encourage hydration for 24 hours after the examination
|Appropriateness Criteria3,4||Metastatic Disease: Indications vary based on the type of malignancy, stage of disease and symptoms.
Benign/Traumatic Lesions: Often radiography is the initial examination of choice; those results determine the next imaging step.
99mTc sodium pertechnetate
123I sodium iodide
|Recommended Adult Administered Activity by
99mTc sestamibi Dual Phase
99mTc sestamibi/99mTc sodium pertechnetate Dual Tracer**
99mTc sestamibi/123I sodium iodide** Dual Tracer
20-30 mCi (740-1,100 MBq) IV
20-30 mCi (740-1,100 MBq) IV/ 1-10 mCi (37-370 MBq) IV
20-30 mCi (740-1,100 MBq) IV/ 0.2-0.6 mCi (7.5-22 MBq) PO
99mTc sestamibi Dual Phase protocol has a lower radiation exposure than subtraction techniques; it may have a lower sensitivity in “Multiple Parathyroid Gland Disease.”
Maximize the diagnostic potential of the examination:
Formal appropriateness criteria do not exist.
Imaging should be preceded by the clinical diagnosis of hyperparathyroidism, which includes appropriate history and laboratory abnormalities (e.g., abnormal serum calcium and parathyroid hormone levels).
**99mTc tetrofosmin has been used in place of 99mTc sestamibi in some protocols, with similar overall results and radiation dosimetry. However, it is less suited to Dual Phase “washout” examinations because it does not show adequate differential washout from thyroid tissue relative to parathyroid tissue.1,3
|Radiopharmaceuticals||123I sodium iodide
99mTc sodium pertechnetate
|Recommended Adult Administered Activity by Protocol8,9
123I sodium iodide for Imaging and Uptake
99mTc sodium pertechnetate for Imaging
131I sodium iodide for Uptake
0.2-0.6 mCi (7.5-22 MBq) PO
2-10mCi (74-370 MBq) IV
0.004-0.01 mCi (0.15-0.37 MBq) PO
|Performance Considerations8,9||123I sodium iodide is preferred for routine use because of its lower radiation exposure to the thyroid compared to 131I sodium iodide.|
|Maneuvers To Minimize Dose8,9||Screen the patient to avoid interfering materials that invalidate the examination: thyroid hormone, iodine containing foods and medications, iodinated contrast, and anti-thyroid medications.|
|Appropriateness Criteria10,11||Thyroid nodules: the appropriate choice of scintigraphy, ultrasound and/or fine needle aspiration, varies with the clinical scenario.|
|Radiopharmaceuticals||123I sodium iodide
131I sodium iodide
|Recommended Adult Administered Activity by Protocol8,12
123I sodium iodide
131I sodium iodide
0.4-5 mCi (15-185 MBq) PO
1-5 mCi (37-185 MBq) PO
131I sodium iodide yields higher radiation exposure than 123I sodium iodide, but after thyroidectomy a patient’s exposure from both tracers tends to be relatively low.
|Appropriateness Criteria11||The appropriate use of radioiodine scintigraphy in patients who are post-thyroidectomy for newly-diagnosed differentiated thyroid carcinoma or are being followed after ablation is not universally agreed upon in all clinical scenarios. The evaluation of candidates for radioiodine scintigraphy should include a consideration of patient factors such as clinicopathologic stage and other risk factors including laboratory data and size of the remnant post-thyroidectomy.|
|Radiopharmaceuticals||99mTc MAA (perfusion, Q)
99mTc DTPA (ventilation, V)
133Xe (ventilation, V)
|Recommended Adult Administered Activity13,14
1-5 mCi (37-185 MBq) IV
20-50 mCi (740-1850 MBq) in the nebulizer
5-30 mCi (185-1,110 MBq) inhaled as gas
|Maneuvers to Minimize Radiation Dose13,14,15,16,17,18||
Guidelines have been developed for patients with suspected pulmonary embolism.
|Recommended Adult Administered Activity22.214.171.124.23
8-10 mCi (300-370 MBq) IV
0.3-0.5 mCi (11-19 MBq); up to 1 mCi (37 MBq) IV in large pts
5-20 mCi (185-740 MBq) IV
Nuclear medicine offers a variety of examinations that detect and localize sites of infection. It is important to choose the radiopharmaceutical protocol that optimizes diagnostic efficacy.
67Ga citrate has the highest radiation exposure, but may be advantageous for the diagnosis of discitis/spinal osteomyelitis (see below), tuberculosis and fungal infections, and chronic infections.
111In leukocytes and 99mTc leukocytes have advantages and disadvantages. For example, 111In leukocytes allow contemporaneous bone marrow (99mTc sulfur colloid) or bone (99mTc HDP/MDP) scans, while 99mTc leukocytes require a 48-hour delay. 99mTc leukocytes have the lowest patient radiation exposure and a photon energy optimal for gamma camera imaging, but radioactivity normally appears in the intestinal and urinary systems, which could limit diagnostic efficacy for infections in the abdomen.
Patient radiation exposure should not be a primary determinant when choosing among these alternatives; the emphasis is choosing the examination with the highest diagnostic efficacy in that particular scenario.
Radionuclide infection imaging encompasses a wide variety of clinical scenarios and the corresponding appropriateness criteria for each particular scenario should be reviewed. In general:
|Radiopharmaceuticals||99mTc iminodiacetic acids(disofenin, mebrofenin)|
|Recommended Adult Administered Activity24,25||3-5 mCi (111-185 MBq) IV
Higher doses may be needed in hyperbilirubinemia.
Mebrofenin may improve exam quality in patients with moderate to severe hepatic dysfunction because of its higher hepatic extraction.
Minimize Sources of Error (False Positive Results) including:
|Appropriateness Criteria25,26, 27||
Right upper quadrant pain: In many clinical scenarios, abdominal ultrasound is the initial exam, because it does not use ionizing radiation, and it can provide morphological assessment, including the presence or absences gallstones and biliary ductal dilation. However, hepatobiliary scintigraphy often has a role due to its slightly higher sensitivity and specificity, particularly in problematic cases.
Jaundice: Hepatobiliary Scintigraphy cannot distinguish intrahepatic cholestasis from mechanical biliary obstruction, which precludes routine use in the jaundiced patient.
Post-operative setting: Identification of bile leak (e.g., after cholecystectomy, transplant, trauma).